An Electrochemical Strategy for Chalcogenation of closo-Dodecaborate (B12H12)2– Anion

13 January 2025, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Advancements in thermal neutron generation technologies within clinical environments have led to a renewed interest in developing boron-containing compounds for boron neutron capture therapy (BNCT). Previous syntheses of several key boron cluster-based therapeutics with clinical relevance are low-yielding and have complicated workup procedures. Using electrolytic methods, we report the in situ oxidation of pseudohalides, –SCN and –SeCN, to synthesize pseudohalogenated products, B12H11YCN2– (Y = S or Se). Further, these compounds can be reduced to their respective thiol or selenol, BSH or BSeH, which are exceedingly nucleophilic and able to form zwitterionic sulfonium and selenonium compounds using alkyl-based electrophiles. The newly reported preparation of BSH and BSeH provides an efficient and convenient route to the preparation of key chalcogenated boron cluster building blocks for the biomedical and materials science communities.

Keywords

boron cluster
dodecaborate
boron neutron capture therapy
selenol
thiol

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.